William Ho

Hospital Authority — China

Medicine · Health Sciences

22h-index5.4kcitations50works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(18), Immunotherapy and Immune Responses(13), T-cell and B-cell Immunology(11), Immune Cell Function and Interaction(10), Monoclonal and Polyclonal Antibodies Research(9)

Publications50 total

Optimize Patient Safety and Operational Efficiency Through a Closed-Loop Specimen Tacking System
Studies in health technology and informatics·2025· 1 citedOpen Access
Establishment of the Institute for Medical Advancement and Clinical Excellence (IMACE)
Hong Kong Medical Journal·2025Open Access
Transcriptomic characterisation of acute myeloid leukemia cell lines bearing the same t(9;11) driver mutation reveals different molecular signatures
BMC Genomics·2025· 2 citedOpen Access
Abstract CT226: Phase 2 study of oral CCR4 antagonist FLX475 (tivumecirnon) plus pembrolizumab in subjects with head and neck squamous cell carcinoma (HNSCC) previously treated with checkpoint inhibitor
Cancer Research·2024· 5 cited
Phase I trial of drug resistant immunotherapy: A first-in-class combination of MGMT-modified γδ t cells and temozolomide chemotherapy in newly diagnosed glioblastoma multiforme.
Journal of Clinical Oncology·2020
Therapeutic Potential of Cells of the Immune System
Elsevier eBooks·2020
An analysis of inhibitory functioning in individuals with chronic posttraumatic stress disorder
Journal of Anxiety Disorders·2015· 17 cited
A Phase I Study of IGN523, a Novel Anti-CD98 Monoclonal Antibody in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
Blood·2015· 14 cited
A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: Correlation between clinical responses and AUC pharmacokinetics
Clinical Immunology·2014· 26 citedOpen Access
Poster: Reflections of Western Values in Video Games about War
2014
DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma
Molecular Cancer Therapeutics·2013· 83 cited
Transferred WT1-Reactive CD8 <sup>+</sup> T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients
Science Translational Medicine·2013· 306 cited
A Phase I Study of DCDT2980S, an Antibody-Drug Conjugate (ADC) Targeting CD22, in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
Blood·2012· 12 cited
A Phase I Study of the Anti-CD79b Antibody-Drug Conjugate (ADC) DCDS4501A Targeting CD79b in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
Blood·2012· 16 cited
Preliminary Results of a Phase II Open-Label, Randomized Study of the BH3 Mimetic Protein Navitoclax (ABT-263) with or without Rituximab for Treatment of Previously Untreated B-Cell Chronic Lymphocytic Leukemia
Blood·2012· 10 cited
A Phase I Study of the Safety and Pharmacokinetics of Escalating Doses of MFGR1877S, a Fibroblast Growth Factor Receptor 3 (FGFR3) Antibody, in Patients with Relapsed or Refractory t(4;14)-Positive Multiple Myeloma
Blood·2012· 18 cited
Transferred Donor-Derived WT1-Specific CD8+ T-Cell Clones After Hematopoietic Cell Transplantation Mediate Antileukemic Activity and Can Establish Persistent Responses without Toxicity to Normal Tissues in High-Risk Leukemia Patients
Blood·2012
Oral Direct-Acting Antiviral Therapy for Hepatitis C
Journal of Antivirals & Antiretrovirals·2012
Investigational antibody-drug conjugates for hematological malignancies
Expert Opinion on Investigational Drugs·2010· 71 cited
A Phase I Study of PRO131921, a Novel Anti-CD20 Monoclonal Antibody in Patients with Relapsed/Refractory CD20+ Indolent NHL: Correlation Between Clinical Responses and AUC Pharmacokinetics.
Blood·2009· 15 cited
page 1 of 3Next →

Frequent Co-authors

Philip D. Greenberg(14), Matthias Wölfl(8), Cassian Yee(7), Mark M. Davis(6), Hieu Nguyen(5), Michelle L. Dossett(5), Carla Fowler(4), Juergen Kuball(4), Christopher C. Goodnow(3), Aude G. Chapuis(3), Gunnar B. Ragnarsson(3), Jerome Schaack(3), Yu‐Waye Chu(3), Mark W. Brunvand(3), André Goy(3), Bruce D. Cheson(3), Ryan M. Teague(3), Joe Blattman(3), Michael P. Cooke(2), Jürgen Kuball(2)